Who
Tuan Nguyen
Chief Financial Officer
Company insider
Files Form 4 as: Chief Financial Officer, Arbutus Biopharma.
In numbers
- Trades disclosed
- 17
- Buys
- 0
- Sells
- 0
- Bought
- $0
- Sold
- $0
- Companies
- 1
- Companies where not an officer
- 0
- First trade
- 31 Mar 2025
- Last trade
- 1 Oct 2026
- Last filed
- 7 Oct 2026
Companies traded
Activity over time
Not enough dated trades to draw.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 1 Oct 2026filed 7 Oct 2026 | ABUS Arbutus BiopharmaBiotechnology | SEC FORM 4 Code D | $240K48,081 at $5.00 | filing |
| 18 Sep 2026filed 23 Sep 2026 | ABUS Arbutus BiopharmaBiotechnology | SEC FORM 4 Code M | $927K265,625 at $3.49 | filing |
| 18 Sep 2026filed 23 Sep 2026 | ABUS Arbutus BiopharmaBiotechnology | SEC FORM 4 Code M | $121K27,475 at $4.39 | filing |
| 18 Sep 2026filed 23 Sep 2026 | ABUS Arbutus BiopharmaBiotechnology | SEC FORM 4 Code F | $1.0M206,637 at $5.07 | filing |
| 18 Sep 2026filed 23 Sep 2026 | ABUS Arbutus Biopharmaoption or derivative · Biotechnology | SEC FORM 4 Code M | —265,625 at $0.00 | filing |
| 18 Sep 2026filed 23 Sep 2026 | ABUS Arbutus Biopharmaoption or derivative · Biotechnology | SEC FORM 4 Code M | —27,475 at $0.00 | filing |
| 18 Sep 2026filed 23 Sep 2026 | ABUS Arbutus Biopharmaoption or derivative · Biotechnology | SEC FORM 4 Code M | —265,625 at $0.00 | filing |
| 18 Sep 2026filed 23 Sep 2026 | ABUS Arbutus Biopharmaoption or derivative · Biotechnology | SEC FORM 4 Code M | —27,475 at $0.00 | filing |
| 18 Sep 2026filed 23 Sep 2026 | ABUS Arbutus BiopharmaBiotechnology | SEC FORM 4 Code M | $927K265,625 at $3.49 | filing |
| 18 Sep 2026filed 23 Sep 2026 | ABUS Arbutus BiopharmaBiotechnology | SEC FORM 4 Code M | $121K27,475 at $4.39 | filing |
| 18 Sep 2026filed 23 Sep 2026 | ABUS Arbutus BiopharmaBiotechnology | SEC FORM 4 Code F | $1.0M206,637 at $5.07 | filing |
| 2 Feb 2026filed 2 Feb 2026 | ABUS Arbutus BiopharmaBiotechnology | SEC FORM 4 Code A | —73,500 at $0.00 | filing |
| 2 Feb 2026filed 2 Feb 2026 | ABUS Arbutus Biopharmaoption or derivative · Biotechnology | SEC FORM 4 Code A | —188,400 at $0.00 | filing |
| 2 Feb 2026filed 2 Feb 2026 | ABUS Arbutus Biopharmaoption or derivative · Biotechnology | SEC FORM 4 Code A | —188,400 at $0.00 | filing |
| 2 Feb 2026filed 2 Feb 2026 | ABUS Arbutus BiopharmaBiotechnology | SEC FORM 4 Code A | —73,500 at $0.00 | filing |
| 31 Mar 2025filed 1 Apr 2025 | ABUS Arbutus Biopharmaoption or derivative · Biotechnology | SEC FORM 4 Code A | —750,000 at $0.00 | filing |
| 31 Mar 2025filed 31 Mar 2025 | ABUS Arbutus Biopharmaoption or derivative · Biotechnology | SEC FORM 4 Code A | —750,000 at $0.00 | filing |
News
No headline names them, or the companies they trade most, lately.
Sectors
No trade we could place in a sector.